GSK plc ADR buy Citigroup Inc.
Start price
26.06.24
/
50%
€36.40
Target price
26.06.25
-
Performance (%)
-10.44%
End price
27.06.25
€32.60
Summary
This prediction ended on 27.06.25 with a price of €32.60. The price of GSK plc ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.44%. Dividends of €1.10 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | -5.385% | -5.385% | 35.165% |
| iShares Core DAX® | -3.986% | -2.814% | 4.157% |
| iShares Nasdaq 100 | 0.345% | -0.748% | 9.471% |
| iShares Nikkei 225® | -3.853% | 4.229% | 28.358% |
| iShares S&P 500 | 0.298% | 0.379% | 6.139% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten